Analysis of Jumping in Patients With Ankle Instability (Ankle-optogait) (Ankle-optoga)

The study is, in accordance with current legislation, definable as a single-center interventional study with evaluations carried out at a single timeframe.

The objective of the study is to compare jumping performance between subjects with ankle instability and healthy volunteer subjects.

In particular, the primary objective is to verify the difference in the monopodalic CMJ value of the diseased limb of subjects with ankle instability compared to the control group at time 0.

The population is made up of patients suffering from ankle instability and a control group of healthy volunteers, divided as follows:

25 subjects GROUP A: Study group: patients suffering from ankle instability

25 subjects GROUP B: control group: healthy voluntary subjects not affected by ankle pathology

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

Ankle sprains are one of the most common injuries during sports activity which often results in chronic instability of the ankle, characterized by a feeling of sagging more or less associated with pain with impairment of sports activity.

Numerous authors have suggested that there is altered peripheral neuromuscular control in patients with ankle instability with limitations related to proprioception, neuromuscular control, or strength, leading to deficits not only of the ankle joint but of the entire inferior kinetic chain Jumping is a simple gesture, present in almost every sporting activity, and its evaluation has proven to be a reliable parameter in terms of partisan capacity.

Patients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects.

T0

  • Explanation of the study and written informed consent.
  • Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments.
  • AOFAS Rating Scales,
  • Tegner activity level
  • Vertical Jump Test (CMJ) using OptoGait platform using a battery of monopodalic jumps.
  • Drop jump using an OptoGait platform using a battery of monopodalic jumps
  • Side hop test using an OptoGait platform using a battery of monopod jumps

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Milan, Italy
        • Istituto Clinico San Siro

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Athletes of legal age (aged between 18 and 45 years inclusive) suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability (study group).
  • Athletes of legal age (aged between 18 and 45 years) who are not symptomatic for ankle diseases (control group)
  • Signing of the Informed Consent and consent to collaborate in all study procedures.

Exclusion Criteria:

  • Minors
  • Pregnant women (self-declaration)
  • patients with BMI ≥ 30
  • patients with orthopaedic, muscular and neuromuscular problems at the time of performing the jump
  • Non-acceptance of informed consent
  • Patients with previous unilateral or contralateral ankle reconstructive surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients suffering from ankle instability

Patients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects.

T0 Explanation of the study and written informed consent.

  • Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments.
  • AOFAS Rating Scales,
  • Tegner activity level
  • Vertical Jump Test (CMJ) by foot pedal
Active Comparator: Healthy volunteer subjects not affected by ankle pathology

Patients suffering from chronic ankle instability symptomatic of recurrent subjective and objective instability will be considered. Patients will be compared to a control group of healthy volunteer subjects.

T0 Explanation of the study and written informed consent.

  • Verification of inclusion/exclusion criteria and verification of previous or ongoing treatments.
  • AOFAS Rating Scales,
  • Tegner activity level
  • Vertical Jump Test (CMJ) by foot pedal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
verify the difference in the monopodalic CMJ (countermovement jump test) of the diseased limb of subjects with ankle instability compared to the control group
Time Frame: Day 0
verify the difference in the monopodalic CMJ (countermovement jump test) value of the diseased limb of subjects with ankle instability compared to the control group at time 0
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 28, 2022

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

July 1, 2025

Study Registration Dates

First Submitted

March 4, 2024

First Submitted That Met QC Criteria

March 15, 2024

First Posted (Actual)

March 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 15, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Ankle-optogait

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ankle Disease

Clinical Trials on jumping performance

Subscribe